首页 > 最新文献

Oncology Times最新文献

英文 中文
Antitumor Activity With Belzutifan in Advanced Clear Cell RCC 贝珠替凡对晚期透明细胞 RCC 的抗肿瘤活性
Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009908.72202.ed
Dibash Kumar Das
{"title":"Antitumor Activity With Belzutifan in Advanced Clear Cell RCC","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009908.72202.ed","DOIUrl":"https://doi.org/10.1097/01.cot.0001009908.72202.ed","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"7 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140083367","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Belantamab Combination Offers PFS Benefit in R/R Multiple Myeloma 贝仑单抗复方制剂为急性/慢性多发性骨髓瘤患者带来疗效
Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009948.60927.e0
M. Fuerst
{"title":"Belantamab Combination Offers PFS Benefit in R/R Multiple Myeloma","authors":"M. Fuerst","doi":"10.1097/01.cot.0001009948.60927.e0","DOIUrl":"https://doi.org/10.1097/01.cot.0001009948.60927.e0","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"60 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140085565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Breast Cancer-Related Health Disparities in Black Women 与乳腺癌相关的健康差异对黑人妇女的影响
Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009912.17568.36
F. Wiley
{"title":"The Impact of Breast Cancer-Related Health Disparities in Black Women","authors":"F. Wiley","doi":"10.1097/01.cot.0001009912.17568.36","DOIUrl":"https://doi.org/10.1097/01.cot.0001009912.17568.36","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":" 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140091388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of NGS Mutation Signature on MMR Testing for Immunotherapy NGS 基因突变特征对麻风腮免疫疗法检测的影响
Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009872.61780.4a
Dibash Kumar Das
{"title":"The Impact of NGS Mutation Signature on MMR Testing for Immunotherapy","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009872.61780.4a","DOIUrl":"https://doi.org/10.1097/01.cot.0001009872.61780.4a","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":" 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140091642","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR-T Cells to Control Multiple Myeloma Growth 控制多发性骨髓瘤生长的 CAR-T 细胞
Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009944.34160.61
Dibash Kumar Das
{"title":"CAR-T Cells to Control Multiple Myeloma Growth","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009944.34160.61","DOIUrl":"https://doi.org/10.1097/01.cot.0001009944.34160.61","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"29 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140084223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mental Health Issues Among AML Patients on Venetoclax 服用 Venetoclax 的急性髓细胞白血病患者的心理健康问题
Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009924.21900.ae
M. Fuerst
{"title":"Mental Health Issues Among AML Patients on Venetoclax","authors":"M. Fuerst","doi":"10.1097/01.cot.0001009924.21900.ae","DOIUrl":"https://doi.org/10.1097/01.cot.0001009924.21900.ae","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"70 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140085160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How to Harmonize Variability in AI Biomarker Assessment Tools 如何协调人工智能生物标志物评估工具的差异性
Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009840.08322.11
P. Eastman
{"title":"How to Harmonize Variability in AI Biomarker Assessment Tools","authors":"P. Eastman","doi":"10.1097/01.cot.0001009840.08322.11","DOIUrl":"https://doi.org/10.1097/01.cot.0001009840.08322.11","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"17 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140084005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring Early Detection Saliva Epigenetics for Esophageal Cancer 探索食道癌的早期检测唾液表观遗传学
Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009916.27689.45
Dibash Kumar Das
{"title":"Exploring Early Detection Saliva Epigenetics for Esophageal Cancer","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009916.27689.45","DOIUrl":"https://doi.org/10.1097/01.cot.0001009916.27689.45","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"65 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140085341","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Olutasidenib as a Breakthrough for R/R mIDH1 AML Patients Olutasidenib 是治疗 R/R mIDH1 AML 患者的突破性药物
Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009932.86369.ce
Dibash Kumar Das
{"title":"Olutasidenib as a Breakthrough for R/R mIDH1 AML Patients","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009932.86369.ce","DOIUrl":"https://doi.org/10.1097/01.cot.0001009932.86369.ce","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"114 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140089590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tactics of Multiple Myeloma in Evading Targeted Immunotherapies 多发性骨髓瘤逃避靶向免疫疗法的策略
Pub Date : 2024-03-01 DOI: 10.1097/01.cot.0001009844.75140.19
Dibash Kumar Das
{"title":"Tactics of Multiple Myeloma in Evading Targeted Immunotherapies","authors":"Dibash Kumar Das","doi":"10.1097/01.cot.0001009844.75140.19","DOIUrl":"https://doi.org/10.1097/01.cot.0001009844.75140.19","url":null,"abstract":"","PeriodicalId":510505,"journal":{"name":"Oncology Times","volume":"58 23","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140085713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Oncology Times
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1